Streptomyces species and other Actinobacteria are ubiquitous in diverse environments worldwide 17 and are the source of, or inspiration for, the majority of pharmaceuticals. The genomic era has enhanced 18 biosynthetic understanding of these valuable chemical entities and has also provided a window into the 19 diversity and distribution of natural product biosynthetic gene clusters. Antimycin is an inhibitor of 20 mitochondrial cytochrome c reductase and more recently was shown to inhibit Bcl-2/Bcl-XL-related anti-21 apoptotic proteins commonly overproduced by cancerous cells. Here we identify 65 putative antimycin 22 biosynthetic gene clusters (BGCs) in publicly available genome sequences of Actinobacteria and classify 23 them based on the presence or absence of cluster-situated genes antP and antQ, which encode a 24 kynureninase and phosphopantetheinyl transferase (PPTase), respectively. The majority of BGCs possess 25 either both antP and antQ (L-form) or neither (S-form), while a minority of them lack either antP or 26 antQ (IQ-or IP-form, respectively). We also evaluate the biogeographical distribution and phylogenetic 27 relationships of antimycin producers and BGCs. We show that antimycin BGCs occur on five of the 28 seven continents and are frequently isolated from plants and other higher organisms. We also provide 29 evidence for two distinct phylogenetic clades of antimycin producers and gene clusters, which delineate 30 S-form from L-and I-form BGCs. Finally, our findings suggest that the ancestral antimycin producer 31 harboured an L-form gene cluster which was primarily propagated by vertical transmission and 32 subsequently diversified into S-, IQ-and IP-form biosynthetic pathways. 33 34
Intriguingly, subsequent identification of antimycin biosynthetic pathways in other taxa revealed 68 that the BGC possesses up to four architectures [17] . Short-form (S-form, 15 genes), intermediate-form 69 (IQ-or IP-form, 16 genes) and long-form (L-form, 17 genes), based on the absence (S-form) or presence 70 (L-form) of two cluster-situated genes, antP and antQ, which encode a kynureninase and 71 phosphopantetheinyl transferase, respectively. I-form BGCs harbour either antP (IP) or antQ (IQ), but not 72 both ( Fig. 1) . How the antimycin BGC evolved into these various architectures is an intriguing question 73 and one that we sought to address with this study. 74
Here we identify 73 antimycin BGCs (six known and 67 putative) in publicly available genome 75 sequences of Actinobacteria and evaluate their biogeographical distribution and phylogenetic 76 relationships. Isolation metadata suggests that the antimycin BGC has a large biogeographical range, 77 with isolation of putative antimycin producers from at least five continents. Our phylogenetic analyses 78 support the existence of two distinct clades of antimycin producers and BGCs which delineate S-form 79 from L-and I-form BGCs. Finally, our findings suggest that the ancestral antimycin producer harboured 80 an L-form BGC that was primarily propagated by vertical transmission and subsequently diversified into 81 S-, IQ-and IP-form biosynthetic pathways. 82
Results and discussion 83
Identification of putative antimycin biosynthetic gene clusters (BGCs) in Actinobacteria. 84 Established and putative antimycin BGCs were previously identified within the genomes of 14 85
Streptomyces species [17] , however casual analyses of the genome sequences available in GenBank 86 suggested that this number is likely to be far greater. In order to formally assess this possibility, 1,421 87 publically available genome sequences for select Actinobacteria genera (i.e. those with a history of 88 natural products production: (Actinobactera, Actinomadura, Actinospica, Amycolatopsis, Kitasatospora, 89 Micromonospora, Nocardia, Saccharopolyspora, Planomonospora, Pseudonocardia, Salinispora, 90 Streptacidiphilus, and Streptomyces) were downloaded and annotated using Prokka 1.12 [18] . The 91
Prokka annotation enabled the construction of a customised mutligeneblast database, which was 92 subsequently used in conjunction with the antFGHIJKLMNOPQ genes from S. ambofaciens and 93 multigeneblast 1.1.13 [19] to generate a list of taxa harbouring a putative antimycin BGC. The genes 94 antFGHIJKLMNOPQ were selected on the basis that they are essential for antimycin biosynthesis and 95 are conserved in all established antimycin BGCs; antPQ were included in order to permit the tentative 96 classification of gene cluster architecture (see below). Close inspection of gene clusters from the 97 candidate list resulted in the identification of an antimycin BGC in 73 taxa (six known and 67 putative) 98 (Table 1) . Among these, five are described as non-Streptomyces species: Saccharopolyspora flava DSM 99 44771, Streptacidiphilus albus JL83, Streptacidiphilus albus NBRC 100918, Actinospica acidiphila 100 NRRL B-24431 and Actinobacteria bacterium OV320 (Table 1) . 101
Inspection of loci identified as encoding 3-formamidosalicylate biosynthetic genes revealed a few 102 noteworthy peculiarities. Streptomyces albus subsp. albus strain NRRL B-2513 possesses a clear 3-103 formamidosalicylate locus, but lacks antM and the core NRPS-PKS biosynthetic machinery at this locus 104 or elsewhere in the genome, and Streptomyces phaeoluteigriseus strain DSM 41896 has endured at least 105 two frameshift mutations in antD, which presumably render it non-functional. In addition, Streptomyces 106 lincolnensis strain NRRL 2936, Streptomyces sp. yr375 and Streptomyces sp. ERV7 each harbour the 6 same antimycin-like BGC, however gene rearrangement and insertion is evident, for example a small 108 locus of fatty acid anabolism genes has been inserted between the 3-formamidosalicylate biosynthetic 109 genes and the NRPS-PKS machinery, suggesting that the biosynthetic pathway may not in fact produce 110 antimycins. These taxa and BGCs were discarded as a consequence of these peculiarities. 111
Classification of antimycin BGCs. Antimycin BGCs exist in four architectures and the gene 112 clusters identified here were classified as short-form (S-form, 15 genes), intermediate-form form, 16 genes) and long-form (L-form, 17 genes), based on the absence (S-form) or presence (L-form) 114 of two cluster-situated genes, antP and antQ, which encode a kynureninase (InterPro ID, IPR010111) 115 and a phosphopantetheinyl transferase (InterPro ID, IPR0082788), respectively. The organisation of the 116 genes within antimycin BGCs and their functions are described in Fig. 1 and Table 2 , respectively. 117 Annotation of the putative biosynthetic pathways identified above resulted in the classification of 25 S-118 form, 13 IP-form, five IQ-form and 30 L-form antimycin BGCs (Table 1) . 119
Interestingly, the conditional loss of antP and antQ relates to consumption of tryptophan and 120 maturation of the biosynthetic assembly line to its pantetheinylated form. AntF activates anthranilate as 121 the first step in the biosynthesis of the 3-formamidosalicylate starter unit. All forms of the antimycin 122 biosynthetic pathway are able to access anthranilate from the 'core' anthranilate pool within the cell, 123 evidenced by feeding studies with exogenous fluoroanthranilates [16] . However, only L-and IP-form 124 pathways harbour a gene encoding a putative kynureninase (AntP), which presumably processes the 125 kynurenine produced by the AntN tryptophan 2,3-dioxygenase to anthranilate. S-and IQ-form pathways 126 lack a kynureninase and must rely upon the housekeeping kynureninase involved in tryptophan 127 catabolism. The maintenance of antP by L-and IP-forms and its loss by S-and IQ-forms may be driven 128 by differences in species-level physiology, for instance the availability of cytosolic anthranilate. It is 129 perhaps not surprising that AntQ is not essential in S-and IP-forms; in fact, most NRPS and PKS 130 biosynthetic systems lack a cluster-situated PPTase and are dependent on the promiscuity of one or more 131 7 BGCs, but it may not be for L-form antimycin BGCs, as antimycin production by S. ambofaciens requires 133 both antQ and a PPTase encoded elsewhere in the genome that is similar to SCO6673 from S. coelicolor 134 A3(2) [20] . The contextual requirement of antP and antQ for antimycin biosynthesis creates the 135 opportunity for divergent evolution of the antimycin BGC. 136
Biogeographical distribution of antimycin biosynthesis. The biogeography of natural products 137 biosynthesis is an emerging area and one that can not only guide future natural products bioprospecting 138 campaigns, but which enables formulation of interesting questions in chemical microbial ecology 139 [21, 22] . Thus, we curated isolation metadata for putative antimycin producers to ascertain any patterns 140 in source material or its geographical origin. The breadth of data varied considerably, but a source and/or 141 country location was available in GenBank or within the literature for 38 out of 73 strains (Table 1) . 142
Sample collection data were plotted onto a World map and pins were colour coded based on gene cluster 143 architecture. Inspection of the resulting map did not show an obvious link between gene cluster 144 architecture and geographical location, but did reveal that putative antimycin producers have been 145 isolated from a relatively large geographical area, including at least five of the seven continents: Africa, 146
Asia, Europe, North America and South America (Fig. 2) . Only a single strain originates from the 147 Southern Hemisphere, which is surprising however this is likely a consequence of the inherent limitations 148 of the dataset. Like geographical location, gene cluster architecture and isolation source material do not 149 appear to be related, however, as anticipated, many strains originate from various soil ecosystems (17 in 150 total) or marine sediments (four in total), which supports the longstanding view that these niches are rich 151 sources of bioactive metabolites. Interestingly, 18 of the strains were isolated from plants, sponges or 152
insects, suggesting that they may be involved in symbioses, which is in line with the increasing number 153 of reports implicating antibiotic-producing taxa as defensive symbionts of higher organisms [23, 24] . 154
Overall, these data suggest that antimycin-producing Actinobacteria are likely distributed worldwide, 155 which may reflect the significance of producing an inhibitor of eukaryotic cytochrome c reductase in 156 diverse niches. 157 8 Distribution of antimycin BGCs within Actinobacteria. The collection of putative antimycin 158
BGCs identified here provides an opportunity to further explore their phylogenetic and evolutionary 159 relationships. A multilocus phylogeny was reconstructed in order to evaluate the taxonomic distribution 160 of antimycin BGCs. Phylosift was used to identify and extract phylogenetic markers from the genome of 161 each microbe described in Table 1 . This resulted in the identification of 29 phylogenetic markers present 162 in single copy in each taxon (see Table S1 for description of markers). The markers were concatenated, 163 aligned (length 13,119 nt) and used to infer a maximum likelihood (ML) phylogenetic tree ( Fig. 3) . 164
Inspection of the resulting phylogeny suggested that six taxa have been taxonomically miss assigned. 165
For instance, Actinospica acidiphila strain NRRL B-24431 and Actinobacteria bacterium strain OV320 166 group closely with Streptomyces species placed within the interior of the tree and are therefore likely to 167 be members of the genus Streptomyces (Fig. 3) . Additionally, four taxa designated as S. griseus (S. 168 griseus subsp. griseus NRRL B-2307, S. griseus subsp. griseus NRRL F-5618, S. griseus subsp. griseus 169 NRRL F-5621, S. griseus subsp. griseus NRRL WC-3066) group within the S. albus J1074 clade and are 170 thus likely strains of this species and not strains of the streptomycin producer, S. griseus. 171
Next, the phylogenetic tree was colour-coded based on the gene cluster architectures determined 172 above. The sixth bifurcation divides the tree into two major clades, one which contains 24 of the 25 taxa 173 harbouring an S-form antimycin BGC (Clade I), and a second one that contains taxa harbouring 174 exclusively IP-, IQ-and L-form antimycin BGCs (Clade II, Fig. 3 ). Within Clade I, all 24 S-form taxa 175 are closely related to S. albus J1074 and are likely strains of this species. Sequenced strains of S. albus 176 are very prevalent within GenBank, which presumably is a consequence of the ease with which they are 177 isolated and cultivated in the laboratory and their ability to strongly inhibit the growth of pathogenic 178 yeasts in bioactivity assays due to antimycin production [25] . Within Clade II, 50% of the L-form 179 antimycin BGCs are harboured by taxa that comprise a single subclade near the top of the tree which 180 includes several isolates from the United States Department of Agriculture NRRL collection as well as, 181
A. acidiphila NRRL B-24431 ( Fig. 3) . The remaining L-form antimycin BGCs are harboured by small 9 groupings of taxa as well as singletons ( Fig. 3 ). Interspersed amongst L-form taxa are those that harbour 183 IQ-and IP-form gene clusters. For instance, four of the five taxa that harbour an IQ-form antimycin BGC 184 comprise a monophyletic clade situated on a branch sister to that of S. ambofaciens ATCC 23877 ( Fig.  185 3), and 11 out of 13 IP-form antimycin BGCs group into two subclades. Overall, these data suggest that 186 speciation is likely the primary driver for dissemination of the antimycin BGC, which is consistent with 187 the low sequence divergence for taxa closely related to S. albus J1074 within Clade I and the formation 188 suggests that these strains may be closely related to the ancestral antimycin producer or that the genes 192 for antimycin biosynthesis were horizontally acquired by these strains (Fig. 3) . with the ancestral antimycin BGC (Fig. 4) . 211
Antimycin BGC evolution. There are obvious similarities between the species and BGC trees. For 212 instance, both trees bifurcate to separate S-form from IQ-, IP-and L-form taxa and BGCs. This combined 213
with the presence of gene cluster architecture subclades in both trees suggests that speciation has been 214 the primary driver for dissemination of the antimycin BGC. With respect to the both the species and BGC 215 trees, it is reasonable to propose that antimycin biosynthesis evolved once and that the ancestral 216 antimycin producer harboured an L-form BGC. To test this hypothesis, a likelihood analysis was used to 217 predict the ancestral node for each architecture of the antimycin BGC based on its distribution within the 218 phylosift phylogeny. As expected, the likelihood analysis predicted that the ancestral antimycin producer 219 harboured an L-form BGC (Fig. 5) . This supports a model in which loss of antP and/or antQ, rather than 220 their frequent independent acquisition, resulted in diversification of gene cluster architecture. The Although the phylosift and BGC trees are consistent with that proposed above, there is noticeable 231 discordance between the two phylogenies. The most profound of these are highlighted below. Three 232 11 closely related taxa, S. gancidicus, S. sp. NRRL S-1314 and S. sp. NRRL F-5527 group within the large 233 subclade of L-form BGCs in Clade II of the phylosift tree, but shift to occupy a distantly related lineage 234 in Clade II of the antFGHIJKLMNO phylogeny. This suggests that the parent of the S. gancidicus 235 subclade likely received its L-form gene cluster by horizontal gene transfer. The same is also likely true 236 for S. sp. NRRL B-24085, which is located within the centre of Clade II in the phylosift tree, but then 237 joins the large L-form subclade of Clade II in the BGC tree. Interestingly, Sacharropolyspora flava DSM 238 44771, which is an 'outlier' in the phylosift tree (i.e. does not group within Clade I or II) becomes part 239 of Clade II in the BGC tree and shares an ancestral node with the three-membered S. gancidicus subclade 240 described above. This suggests that S. flava and the S. gancidicus subclade likely received their antimycin 241 BGC from the same or a closely related ancestor and is consistent with the hypothesis that S. flava 242 originally harboured an L-form BGC, but independently lost antQ to give rise to its IP-form BGC. In 243 addition, three other outliers from the phylosift tree group within Clade II of the BGC tree: S. sp. 244
Root1319, S. sp. Root55 and S. radiopugnans, which suggests that their antimycin BGC was horizontally 245 acquired and moreover that S. radiopugnans likely independently evolved an IQ-form antimycin BGC 246 from the clade founder. 247
Conclusions and perspectives. In this study, 73 antimycin BGCs were identified in the genome 248 sequences of Actinobacteria deposited in GenBank. The isolation data for these strains indicates that 249 antimycin-producing actinomycetes are likely globally distributed, highlighting an important role for 250 inhibiting cytochrome c reductase in diverse ecological niches. The majority of the antimycin BGCs 251 identified contained both the antP kynureninase and the antQ PPTase (L-form) or neither of these (S-252 form), while a minority of the gene clusters lacked either the antP or antQ (IQ-or IP-form, respectively). 253
Phylogenetic analyses revealed two distinct lineages separating S-form from L-, IQ-and IP-form taxa and 254
BGCs and although a handful of taxa appear to have acquired the antimycin BGC via horizontal gene 255 transfer, the primary means for dissemination of the gene cluster is vertical transmission. The contextual 256 requirement of antP and antQ presumably permitted divergent evolution of the antimycin biosynthetic 257 pathway. We propose that the ancestral antimycin producer harboured an L-form antimycin BGC, which 258 spawned two main clades, one composed of S-forms that lack both antP and antQ, and one composed of 259 L-forms with distinct subclades of IP and IQ-forms (Fig. 6) . 260
Materials and methods 261
Identification of putative antimycin biosynthetic gene clusters. The genomes available in GenBank 262 on the 9 th of May 2017 for select genera of Actinobacteria (Actinobactera, Actinomadura, Actinospica, 263
Amycolatopsis, Kitasatospora, Micromonospora, Nocardia, Saccharopolyspora, Planomonospora, 264 Pseudonocardia, Salinispora, Streptacidiphilus, and Streptomyces) were downloaded using the ncbi-265 genome-download python script provided by Kai Blin available at https://github.com/kblin/ncbi-266 genome-download. One thousand four hundred and twenty-one genomes were downloaded in total and 267 were subsequently annotated using Prokka 1.12 [18] . The Unix command grep was used to remove any 268 line containing the string "/gene" and then the Unix command sed was used to edit "/locus_tag" to 269 "/gene". A multigeneblast database was created using the makedb programme of multigeneblast version 270 In order to infer a phylogeny for putative antimycin BGCs, 10 genes (antFGHIJKLMNO) were 291 extracted and aligned using MUSCLE. The resulting alignment was imported into Geneious R8.1.19 and 292 manually trimmed to the same length prior to concatenating sequences in the following gene order: 293
antFGHIJKLMNO. The concatenated alignment was then converted to sequential phylip format and a 294 phylogenetic tree was inferred using PhyML3.0 as above. 295
Likelihood analysis. Reconstruction of the ancestral state was performed essentially as described 296
previously [22] . Briefly, the trace character function of Mesquite v3.2 [30] was used to infer the ancestral 297 node for the antimycin BGC within the species tree. A categorical character matrix for BGC type was 298 created and likelihood calculations were performed using the Mk1 model. 299
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